ARS Pharmaceuticals, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
ARS Pharmaceuticals, Inc. (SPRY) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 4.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2022-03-31.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2025-11-10
- ARS Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2022-03-31 was 4.00%.
- ARS Pharmaceuticals, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 4.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 1 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 3 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 6 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 9 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | 4.00% 10-K · filed 2022-03-31 | ||||
| 2022-09-30 | 4.00% 10-Q · filed 2022-11-02 | ||||
| 2022-06-30 | 5.00% 10-Q · filed 2025-11-10 | 4.00% 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 4.00% 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |